Leslie G. Ford

TL;DR: Among obese patients with CRA, 12 weeks of oral meetformin does not reduce rectal mucosa pS6 or Ki-67 levels, and further research is needed to determine what effects metformin has on the target tissue of origin as metform in continues to be pursued as a colorectal cancer chemopreventive agent.

TL;DR: This trial does not support the use of vitamin D supplementation for breast cancer risk reduction and changes in MD were small and did not significantly differ between the active and placebo groups at 12 months.

TL;DR: An analysis of 52 CCOPs and their research bases participating in the program found that the availability of protocols, involvement with research base activities, a demonstrated link to community physicians, and the use of personal contacts to inform non-CCOP physicians about CCOP activities were important facilitating factors for accruing patients to cancer prevention and control trials.

TL;DR: It is shown that rural patients who were postmenopausal and node negative were more likely than urban patients to have a modified radical mastectomy and less likely to have had an oncology consultation and more likely to receive radiation therapy.

TL;DR: Priorities that emerged include screening, a pre-cancer genome atlas (PreTCGA), HPV vaccines, immunoprevention of noninfectious origins, and overdiagnosis.